The Brain Tumor Program is a multidisciplinary group dedicated to the care of patients with primary brain tumors, brain metastases, recurring brain tumors, and neurological complications of cancer. It is the only multidisciplinary consortium providing comprehensive brain cancer care in southern New England and has gained regional and national recognition.
The physicians of the Brain Tumor Program offer a wide spectrum of advanced strategies for the diagnosis and treatment of brain cancer including microsurgical tumor removal, intraoperative neurophysiological monitoring, specialized genomic profiling, image-guided stereotactic techniques, 3D conformal radiotherapy, stereotactic radiosurgery (gamma knife), and novel, targeted chemotherapies. The program is comprised of the departments of Neurosurgery, Neurology, Medical Oncology, Therapeutic Radiology, Neuropathology, and Neuroradiology. A dedicated patient coordinator facilitates patient appointments and communication, coordinates services, and supports patients and their families.
In addition to novel treatments, the physicians of the Brian Tumor Program conduct clinical trials through Yale Cancer Center for patients with recurring tumors. New trials are also available using immunotherapy treatments.
The expertise of the Brain Tumor Program covers all of the components critical to managing patients with brain tumors: comprehensive evaluation and diagnosis, genomic profiling, leading edge treatment options, thorough follow-up, and psychosocial support. Patients are welcome whether they are newly diagnosed or have already received extensive treatment; patients in need of second surgeries or follow up biopsies are also consulted.
Inquiries from referring physicians, patients, or their families are handled by an experienced patient coordinator. The coordinator ensures that appropriate appointments are made quickly. New patients with brain tumors are usually seen within a couple of days. The patient coordinator also acts as the patient's interface with the various medical specialists who play integral roles in each treatment plan.
Neuro-oncology surgeons, radiation oncologists, neuroradiologists, medical oncologists, neurologists, neuropathologists, and others meet weekly at a Tumor Board Conference to arrive at the most appropriate treatment plan for each patient. Because of the Yale Cancer Center's research and teaching mission, the program members are well acquainted with the most advanced treatment methods. Patients benefit from that knowledge and from specialized resources, such as a dedicated neurological intensive care unit and the latest imaging technologies.
Physicians of the Brain Tumor Program maintain a close working relationship with physicians practicing in the community. Patient referrals are welcome. Referring physicians are provided with regular reports on diagnostic findings and treatment recommendations for their patient.